ZYVERSA THERAPEUTICS, INC. ZyVersa Therapeutics, Inc. announced that two leading nephrologists have joined ZyVersa's Renal Scientific Advisory Board. Daniel C. Cattran, MD : Professor of Medicine, University of Toronto, Senior Scientist, Toronto General Research Institute; Fernando C. Fervenza, MD, PhD: Professor of Medicine, Mayo Graduate School of Medicine, Director of the Nephrology Collaborative Group. Drs.
Cattran and Fervenza join ZyVersa's current team of prominent Scientific Advisors, Sharon G. Adler, MD: Professor of Medicine at David Geffen School of Medicine, UCLA; Chief, Division of Nephrology and Hypertension at Harbor-UCLA Medical Center; and Program Director, Nephrology Fellowship Training Program at Harbor-UCLA Medical Center; Alessia Fornoni, MD, PhD: Professor of Medicine and Chief of Katz Family Division of Nephrology and Hypertension at University of Miami Miller School of Medicine; Debbie S. Gipson, MD, MS: Professor, Department of Pediatrics at University of Michigan and Director of the Kidney Research Network Coordinating Center; Marlene Haffner, MD, MPH: Principal and Founder of Orphan Solutions and former Director of Orphan Products Development at FDA; and Pablo A. Guzman, MD, FAAC: Chief Medical Officer and Chairman of Renal Scientific Advisory Board at ZyVersa Therapeutics.
